Introduction
The seminal observation of Shirai 1 that rat sarcoma cells exhibit robust growth when transplanted into the mouse brain parenchyma, but not when implanted subcutaneously or intramuscularly, set the ground for the common view of the central nervous system (CNS) as an 'immune privileged' organ.
2,3 This experiment was followed by complementary findings that further supported the immune ignorance of the parenchyma: (a) the CNS parenchyma is devoid of classical antigen-presenting cells (APCs), such as dendritic cells; (b) no constitutive expression of MHCI and II histocompatibility antigens is evident on parenchymal cells; and (c) the brain parenchyma does not contain lymphatic vessels. Thus, the term 'immune privilege' was interpreted to indicate a complete absence of immunosurveillance within the CNS. Such immune privilege was thought to be an evolutionary adaptation to protect vital brain structures from the potentially damaging effects of inflammation. 4 This general perception seemed to be corroborated by the assumption that a system such as the brain, which is protected from invading microorganisms by the endothelial blood-brain barrier (BBB) and the epithelial blood-cerebrospinal fluid barrier (BCSFB), can afford to give up immune protection in the form of host defense. This model seemed to be further supported by the notion that the brain is equipped with its own innate immune cell population, the resident microglia.
Accumulated experimental evidence, however, made it clear that the CNS is far from being an organ that is ignored by the immune system. In fact, it is now well established that continuous leukocyte trafficking occurs into the healthy CNS, yet such trafficking is restricted to designated areas; leukocytes patrol from the blood through the choroid plexus into the cerebrospinal fluids (CSF) (reviewed in detail in Ransohoff et al., 5 Engelhardt, 6 and Galea et al.
7
). Importantly, under healthy physiological conditions, there are almost no immune cells that infiltrate from the circulation into the brain parenchyma. Owing to the way immune status of the brain was understood, the only function that has been attributed thus far to the trafficking immune cells present in the CSF is a negative one, namely, the initiation of CNS pathologies and specifically autoimmune diseases. [8] [9] [10] In our view, as will be described in this article, it is very unlikely that the presence of patrolling leukocytes in specific compartments, the CSF and CNS borders (the choroid plexus and the meninges, the entrance ports to the CSF), but still kept within the brain's territory, has no fundamental physiological function.
Over the past decades, circulating lymphocytes, and more specifically T cells that recognize CNS antigens, have been shown to have an essential function in supporting brain's plasticity, in health [11] [12] [13] [14] and after trauma; [15] [16] [17] yet, an understanding of where these needs are met is still in its infancy. In addition, it is becoming clear that even resident microglia, the innate (non-antigen-specific) immune cell residents of the CNS, which can endogenously mediate immediate immune functions in the healthy CNS (extensively reviewed in Hanisch and Kettenmann 18 ), require the assistance of circulating monocytes, which are recruited under pathological conditions. [19] [20] [21] [22] Here, we raise the possibility that CNS immunosurveillance is a critical component of the functioning brain. Yet, according to our model, in contrast to other tissues whose immunesurveillance is ensured by a direct local extravasation of leukocytes from the blood, the CNS, because of its extreme vulnerability, has the privilege of tightly controlling the composition and activity of the patrolling leukocytes. This tight regulation is suggested to be insured by the specific location of these cells, within a dedicated compartment comprised of the brain's borders and fluids, which are equipped with defined immunoregulatory properties. Accordingly, we suggest that the CSF and the CNS borders form a 'privileged' peripheral immune niche within the territory of the brain. Any malfunction in this immunological niche (insufficient number or inadequate activity) may result in impairment of brain's cognitive or emotional activities, failure to restore homeostasis after negative or positive stimuli, poor ability to cope with stressful conditions, onset of quiescent mental diseases, or agerelated dementia. Thus, our new model proposes that not only does the immune system need the brain, a well-established linkage, 23 but that the mind needs the immune system. An immunological interface that resides within the brain's territory, in a restricted niche, and under its control, provides such mind's needs. Yet, this model does not deny that a healthy mind may be damaged by diseased peripheral immunity. 24, 25 This opinion piece summarizes a series of emerging novel principles explaining the immunology of the brain, and their implications to brain function and disease.
'Protective autoimmunity': leukocytes maintain the functioning brain
In light of the immune privileged status of the CNS, 2, 3 and based on the comparison (reviewed in Schwartz et al. 26 ) of neurodegenerative conditions with multiple sclerosis, an inflammatory autoimmune disease of the CNS, it was traditionally believed that the presence of active immune cells in the CNS is harmful, and must, therefore, be eliminated or suppressed. [27] [28] [29] [30] However, over the last decade, various studies suggest that the cross-talk between the brain and the immune cells is more complex than originally thought, as beneficial functions have been identified for circulating immunological elements under defined conditions. 11, 16, 19, 20, [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] The turning point in understanding the beneficial function of peripheral immune cells in brain plasticity emerged from the studies showing that peripheral T lymphocytes recognizing brain antigens (referred to here as 'self-specific T cells'), unlike their negative effect in autoimmune disease, promote recovery after CNS trauma. 16 Analogously, T-cell deficiency was associated with greatly increased neuronal loss after injury, suggesting that T lymphocytes participate in mitigating consequences of acute CNS damage; although their activity is insufficient in the natural state, it is amenable to boosting. 17 On the basis of these results, the concept of 'protective autoimmunity' was formulated 16 (Supplementary Information). Consistent with these findings, adaptive immunity was found to also be a critical factor in coping with various chronic neurodegenerative diseases, such as Alzheimer's disease and amyotrophic lateral sclerosis. [31] [32] [33] [34] [36] [37] [38] [42] [43] [44] [45] [46] Although the mechanisms by which these lymphocytes contribute to repair remain to be fully elucidated, accumulating data suggest that autoreactive T cells shift the microglial/macrophage as well as the reactive astrocyte phenotype to a non-cytotoxic neuroprotective one. 45, 47, 48 Moreover, T-cell-based vaccination augments the recruitment of circulating monocytes, which on differentiation to macrophages exhibits immunomodulating and repairing properties. 19, 21 The most intriguing results are those highlighting the contribution of circulating lymphocytes to the maintenance of the functional plasticity of the healthy brain, raising the possibility that the immune system is involved in the maintenance of the functional integrity of the CNS. 11, 12, 40, 41 Lymphocytes have been shown to control baseline levels of adult hippocampal neurogenesis and hippocampal expression brain-derived neurotrophic factor (BDNF), 11, 40 an important factor in neuronal survival and brain plasticity. Mice deficient in T cells or self-specific T cells exhibit reduced proliferation of neural progenitor cells, leading to a decrease in the number of new mature neurons in the adult brain. Reconstitution of the T-cell pool in immune-deficient mice results in a partial restoration of their neurogenic capacity. In addition, the ability to enjoy the benefits of an enriched environment 49 is also impaired in T-celldeficient mice, suggesting a function of leukocytes also in activity-dependent neurogenesis. 11 Notably, T-cell receptor transgenic mice in which most of the T-cell population is directed to a peptide derived from myelin basic protein (MBP) (named 'T MBP ') have significantly higher levels of adult neurogenesis relative to their wild-type controls. This phenomenon was attributed to the CD4 þ , and not the CD8 þ , subset of T lymphocytes. CNS-specific T cells also contribute to adult neurogenesis in other niches, such as the intact adult spinal cord. 50 Inflammatory-associated activity, in contrast, was shown to be a negative regulator of neurogenesis, [51] [52] [53] suggesting that the type of immune activation critically determines the outcome, and that counting the number of locally activated immune cells cannot predict their destructive or beneficial effect (discussed in detail in Ziv and Schwartz 54 ) . At the functional level, CNS-specific T cells were also found to be required for hippocampal-dependent cognitive abilities, including spatial learning/memory, and expression of genes encoding proteins related to presynaptic activity. 11, 12, 40, 41, 55 In addition to decreased neurogenesis, T-cell-deficient mice and mice deficient in CNS-specific T cells were found to exhibit reduced spatial learning and memory capabilities. 11, 41 Reconstitution of the normal T-cell pool in T-cell-deficient mice restored spatial learning and memory. Moreover, T MBP mice perform better than their wild-type counterparts in spatial learning and memory tasks. Sudden imposition of immune compromise in young mice also caused spatial-memory impairment, suggesting that the lymphocytes constantly maintain the functioning brain throughout life. 55 Similarly, systemic depletion of CD4-positive T lymphocytes, but not of CD8 or B lymphocytes, impaired reversal learning in the Morris water maze, and decreased BDNF expression in the brain. 40 Interestingly, the stress-related signature in the brain is manifested by a reduction in BDNF and in neurogenesis, 56, 57 two aspects of brain plasticity that were found to be impaired in immune-deficient mice.
11 Therefore, it is not surprising that a linkage was found between resilience to stress and circulating leukocytes. 13, 58 Attributing to lymphocytes that recognize brain antigens a function in brain maintenance seems to challenge not only the nature of the brain's immune privilege, but also the paradigm of autoimmunity. Traditionally, self-specific T cells have been viewed as potentially dangerous; these T cells have the potential to attack self-tissue expressing the relevant antigens. Therefore, although the presence of T cells recognizing self-antigens in the immune system of healthy individuals has been recognized for over 30 years, 59 the phenomenon of autoimmunity was studied primarily in the context of autoimmune disease and was viewed as a failure of the regulatory mechanism rather than a purposeful event. 60, 61 According to the theory of 'protective autoimmunity,' a distinction must be made between immunity, which includes the body's self-recognizing supportive immune components, and autoimmune diseases that emerge when control is lost. 62 Despite the mounting data suggesting that circulating lymphocytes support the healthy brain, the anatomical location in which this effective and beneficial dialog takes place has not been resolved, given the fact that the brain parenchyma is practically devoid of circulating leukocytes. Here, we raise the hypothesis that the brain's territory contains a unique immunological niche, within the brain's borders and fluids (CSF), that maintains a selected population of a recently activated leukocytes recognizing self-brain antigens under a strict immunoregulatory milieu. To appreciate our model, it is important to emphasize that the brain is not anatomically uniform with respect to its immunological features.
Immune compartmentalization of the CNS
As early as 1923, Murphy and Sturm 63 showed that the extent of active growth of foreign tumor grafts in the brain varies by brain region. Tumor growth can occur only when the grafted material lies entirely within the brain tissue; if the tumor comes in contact with a ventricle, a cellular reaction occurs, with resultant destruction of the graft. This localization dependency of the immune response has also been shown for other cases. [64] [65] [66] The site-specific immune response within the CNS territory is not a unique characteristic of only the lymphocyte response, as it has also been shown for circulating myeloid cells. 67 The privilege of the CNS seems, therefore, to be compartmentalized. 7 Taking into account the immunological nature of each anatomical site, the CNS can be divided from an immunological point of view into the following compartments: the parenchyma, the CSF, and the structures that assemble the BCSFB, the choroid plexus of the ventricular system and the meninges. The differences that characterize the immune response in these anatomical sites are presented below, with special emphasis on the entry of circulating leukocytes to the healthy CNS.
CNS parenchyma
It is now clear that immune privilege defined as the lack of leukocyte (both myeloid and lymphocyte) trafficking is restricted to the parenchyma. This has been explained by the absence of dendritic cells and lymphatic vessels, and the presence of the BBB, the barrier between the vasculature of the CNS parenchyma and the systemic circulation. The BBB is composed of parenchymal venules that have interendothelial junctions enclosed within the glia limitans. The endothelial cells inhibit transcellular passage of molecules across the barrier using an elaborate network of complex tight junctions, 68 and by extremely low pinocytotic activity. The perivascular space separates the basement membrane attached to the endothelial cells of the vessels from the glia limitans. Within the perivascular spaces, reside professional APCs, termed as perivascular cells. In healthy individuals, the BBB is intact and does not express adhesion molecules that are necessary for leukocyte adhesion and entrance (even of encephalitogenic T cells) to the brain parenchyma. 69 The parenchyma is, however, constitutively occupied by specialized immune cells of the myeloid lineage, the resident microglia (reviewed in detail by Hanisch and Kettenmann 18 ). They are of bone marrow origin and belong to the monocytic lineage; yet, they immigrate to the brain early in life, during embryonic development, 70 and their turnover is debatable. 71 In the healthy brain, the microglia are mostly 'resting.' Despite their name, microglial branches are constantly moving and surveying the surrounding area. 72 Ramified microglia are maintained in a semi-quiescent state that allows them to detect danger, while preserving an immunologically silent environment. 73 Neurons and astrocytes have an important function in suppressing microglial behavior by means of cell-cell contact and the secretion of immunosuppressive factors. 74, 75 The lack of leukocyte trafficking into the CNS parenchyma is further reinforced by the presence of fas ligand-expressing neural cells within this compartment, which induce the apoptosis of incoming fas-positive T cells, irrespective of antigen specificity. 76 Taken together, these lines of evidence suggest that practically no infiltration of circulating leukocytes takes place in the healthy CNS parenchyma. Thus, the perception of CNS immune privilege as lack of immune infiltration is applicable to the healthy parenchyma and has been viewed as the general situation within the entire CNS territory.
BCSFB; the choroid plexus and the meninges Experimental data suggested the presence of leukocytes in the healthy CNS, a phenomenon that is limited to the CNS fluids, the CSF, and its related structures (reviewed in details by Ransohoff et al.
and Engelhardt and Ransohoff 77
). This route of trafficking includes migration from the blood across the choroid plexus, the site of CSF production, or through meningial vessels to the subarachnoid space (SAS), through the BCSFB. 78, 79 Tight junctions between the endothelial cells of the meningial vasculature and between epithelial cells of the choroid plexus form the BCSFB, limit access to the CNS by circulating leukocytes.
Choroid plexuses, specialized tissues responsible for CSF secretion, are located in individual cavities known as ventricles. 80, 81 The capillaries of the choroid plexus lack tight junctions and are fenestrated, whereas tight junctions between the choroid plexus epithelial cells form the basis of the BCSFB. The meninges, the system of membranes through which the CSF flows, enclose the CNS. Although both the meninges and the BBB contain tight junctions in their endothelial structure, 82 the vasculature of the meninges, in contrast to parenchymal microvessels, lack astrocytic ensheathment. 83 Leukocytes that cross the meningial vascular BCSFB enter a region between the arachnoid and pial membranes in which the CSF circulates known as the SAS. 5, 77 Some evidence suggests the possibility of an alternative entry site for immune cells directly into the CSF, through the circumventricular organs, 84 although its relevance for CNS immunosurveillance is unclear. These structures located at strategic positions in the ventricular system (primarily surrounding the third and fourth ventricles), and because of their neurohemal or neurosecretory functions, lack an endothelial BBB. Similar to the choroid plexus, a complex network of tight junctions connecting specialized ependymal cells seal off the CNS from the circumventricular organs. 85 The immune reactivity within the choroid plexus and meninges is similar, in principle, to that of the periphery. The APCs of the CNS are mainly located in these anatomical compartments. 86 These cells are located in the choroid plexus stroma outside the barrier (termed as choroid plexus macrophages), in SASs (meningeal macrophages), and on the apical surface of choroid plexus epithelium (Kolmer cells). 87 Although mechanisms of migration across these BCSFB compartments are not fully defined, endothelial P-selectin was found to mediate T lymphocyte entry into the meninges and choroid plexus. 78, 79, 88 Moreover, murine choroid plexus epithelial, but not endothelial, cells express the integrins, ICAM-1 and VCAM-1. 89 Entrance of circulating leukocytes to the brain's parenchyma even under pathological conditions involves BCSFB transmigration. ICAM-1 and VCAM-1 expression in the choroid plexus are up-regulated under inflammatory conditions, during which de novo expression of MAdCAM-1 is also observed. 89 Recently, the CCR6-CCL20 interaction by subset of pathogenic T cells has been shown to have an important function in facilitating T cell entry into the CNS; 9 this process has been described as the initiation step of experimental autoimmune encephalomyelitis development. Recent imaging studies confirm that the SAS is the first site in which activated T encephalotogenic lymphocytes are reactivated by APCs, and this recognition of cognate antigen results in proliferation and parenchymal infiltration. 8, 90 This phase is followed by activation of parenchymal vasculature, resulting in a two-step process of CNS invasion. 8, 9, 90, 91 Similarly, CD8-mediated CNS inflammation originates in the SAS; myelomonocytic cells recruited by CD8 þ T lymphocytes after CMV infection appear first in the SAS even when the virus is inoculated into the brain parenchyma. 10 Thus, the choroid plexus and the meninges do not fulfill the classical definition of immune privilege defined as the lack of leukocyte infiltration and are more accurately viewed as forming the interface between the circulation and the CNS. An alternative view of the immune privileged status of this compartment will be suggested in the coming sections.
Cerebrospinal fluid
The CSF, earlier regarded as a 'clear' ultrafiltrate of plasma, is, in fact, actively produced by the secretory epithelium of the choroid plexus. 80 CSF circulates from the ventricles through the SAS of the meninges and is mainly resorbed into the venous blood through the arachnoid villi, which are 'outpouchings' of the arachnoid membrane that extend into venous sinuses of the cerebral hemispheres.
As was described above, under physiological conditions, the CNS controls immune cell entry and localizes its immunosurveillance primarily to the CSF, leaving the parenchyma free of circulating leukocytes. 5, 77 The CSF of healthy individuals contains approximately 150 000 cells, > 80% of which are
88,92-97 These cells maintain expression of the lymph node homing markers CCR7 and high expression of L-selectin, and about half express CD69, an activation marker. 98 This expression pattern is characteristic of activated memory T cells that have engaged antigen in secondary lymphoid organs; however, these cells maintain expression of CCR7 and L-selectin, which was linked with their potential ability to return into lymphoid compartments. The cells re-enter the bloodstream and are replaced by newly immigrating lymphocytes approximately every 12 h. CSF T lymphocytes with this phenotype are highly enriched compared with their presence in circulating blood, in which they constitute < 5% of leukocytes, indicating that their CSF accumulation is an actively regulated process. Neutrophils, the main population of circulating blood leukocytes, are rarely detected in the CSF of healthy human beings. There are, however, small numbers of monocytes in the CSF (about 5%) derived from a subpopulation of CCR1 þ and CCR5 þ blood monocytes. 99 It has been proposed that CSF central-memory CD4 þ T lymphocytes carry out routine immunosurveillance of the CNS, by searching within the CSF-filled SASs for antigen presented by meningeal macrophages, many with dendritic cell properties, or by macrophages of the choroid plexus or those in the Virchow-Robin perivascular spaces. 87 Accordingly, in contrast to the common view that no antigen drainage occurs in the CNS, a phenomenon that has been used as an argument supporting CNS immune privilege, the CSF might be a partial functional equivalent of the lymph for the CNS. [100] [101] [102] [103] From the SAS, CSF drains through discrete channels in the cribriform plate into lymphatics in the nasal submucosa and, thus, to the cervical lymph. 104 The parenchyma is exposed to this pathway at the surface of the brain, at the level of the Virchow-Robin spaces that are associated with penetrating arteries continuous with the SAS. Recently, it was shown that this path is used not only by antigen, but also by T cells. 105 It was further shown that fluids drained from the brain skew the immune response toward T helper 2-type responses. 106, 107 Furthermore, there is evidence that intracerebral soluble antigen has a tolerizing effect. For example, an ICV infusion of MBP results in protection against MBP-induced experimental autoimmune encephalomyelitis. 108 Moreover, cervical lymph node cells isolated from mice injected with ovalbumin in the striatum were transferred intravenously to donor mice, effectively protecting them from a delayed-type hypersensitivity response to the same antigen. 109 It is possible that the drainage into cervical lymph nodes, which are responsible for nasal mucosal tolerance, 110 is a mechanism that also ensures a skewed immune response to CNS antigens. Such a skewed response results in a deviated form of immune response, which, as is proposed, benefits both the CNS and the periphery. We suggest that in analogy to the aqueous humor of the eye, 111 another immune privileged organ, which was found to cause immune deviation, the molecular milieu of the CSF creates an immunological environment that can deflect any aggressive activity of these cells to a tightly regulated response. In support of this, rodent and human CSF were reported to suppress effector T-cell proliferation and proinflammatory cytokine production, as well as to cause a non-standard form of macrophage activation. 112, 113 Even with emerging explanations as to how immune cells reach the CSF despite the tight barriers, their function remained a mystery. In our view, it is implausible that the body would allow such a potentially hazardous immune mechanism to exist in a tissue that is so sensitive to immune-mediated damage if its entire function is pathologic. It is even more improbable that such potentially threatening leukocytes are the occupants of a fluid that is supposed to represent an 'ultrafiltrate of the blood,' containing only necessary nutrients and factors and excluding any components that could be damaging. We, therefore, propose that the brain constantly selects from the blood, through an active mechanism within its borders, circulating leukocytes required for its maintenance and repair. How these selected cells support the activity of the mind is explained below.
Linking 'protective autoimmunity' with 'CNS immunosurveillance'
According to our model, CNS immunosurveillance by circulating leukocytes is needed for brain maintenance. In other words, we suggest that the function of 'protective autoimmunity' 16 resides within the territory of the CNS, at its borders and within the CSF. The restriction of a selected immune cell subpopulation to these CSF-related compartments enables the close proximity between essential leukocytes and the functioning brain, on one hand, whereas, on the other hand, through its milieu, 112, 113 the CSF ensures a tight regulation of the potential aggressiveness of these cells.
CNS immunosurveillance was earlier suggested to induce tolerance. 114 Tolerance does not necessarily reflect immune ignorance. 115 We suggest that tolerance, as was also recently proposed by others, is not a condition of non-responsiveness to self, but rather a form of regulated and silently acting immune response (that does not produce the classic markers of immune activation, cell proliferation, and production of inflammatory cytokines). Thus, our model calls for a new view of the brain's privilegeredefined as the privilege to possess an immunological niche with selected peripheral immune cells under its own control. According to our model (schematically presented in Figure 1 ), T cells that recognize their cognate antigens presented at the borders (choroid plexus) of the CNS, and which are, therefore, locally activated are allowed, as was recently shown, 8 to enter the CSF on need. Such self-specific surveying lymphocytes do not enter the healthy parenchyma. Our model further predicts that these lymphocytes, which do not proliferate within the choroid plexus and the CSF, are probably skewed toward an immunoregulatory phenotype, characterized by the production of immunoregulatory cytokines such as IL-4, and the secretion of growth/survival factors, and are, therefore, non-encephalitogenic cells. Although leukocytes are absent from the normal parenchyma, their derived molecules, produced in the borders or in the CSF, can affect parenchymal cellular (neurons, astrocytes, oligodendrocytes, and microglia) and molecular (presynaptic-associated proteins) elements. In support of this model, are in vitro studies showing that IL-4-activated microglia not only do not exhibit proinflammatory properties, but also are a major source of local IGF-1 production. 48 IGF-1, produced either by patrolling lymphocytes or locally by IL-4-activated resident microglia, can regulate neuronal BDNF expression. Moreover, such IL-4-activated microglia can more effectively buffer cytotoxic neurotransmitters 47 and support both neurogenesis and oligodendrogenesis. 116 Our model, together with the existing literature, has led us to formulate 'principles of the immunology of . Activated self-recognizing T lymphocytes patrol the SAS, in which the CSF circulates, in a process termed as immunosurveillance (4) . Under physiological conditions, no infiltration to the CNS parenchyma occurs. Patrolling self-recognizing T cells in both the borders and CSF are skewed toward the Th-2 phenotype, which is associated with the production of IL-4 and the secretion of growth/survival factors, such as IGF-1. Reactivation within the CP or the SAS by MHC-II-expressing APCs results in the secretion of these factors into the CSF, by either the self-recognizing T cells or the activated APCs (5). These factors, through the CSF circulation, reach the parenchyma (6) . Either by acting on mature dentate gyrus neurons (7) or by shifting the phenotype of resident microglia (8), these factors result in the local secretion of BDNF (9) and in increased neurogenesis (10) . Note, the CSF tightly controls the aggressiveness of the self-reactive lymphocytes through the secretion of regulatory molecules.
the mind' that we believe explain the missing links between CNS health and disease, as a reflection of CNS immunosurveillance function and malfunction, respectively.
The emerging 'principles of the immunology of the mind'
The players: Both innate immune cells (cells of the myeloid lineage) and adaptive immune cells (antigen-specific cells, such as T lymphocytes) reside in the healthy brain and are an integral part of its functioning. The innate component comprises distinct subpopulations including the predominant population of resident microglia; 18 occupants of the CNS parenchyma, the APCs residing within CNS borders; 87 and another minor population of surveying monocytes, which traffic from the circulation to the surrounding fluids. 99 The adaptive immune cells in the CNS are patrolling lymphocytes, predominantly recently activated memory CD4 þ T cells, which continuously survey the CNS, but remain restricted to the borders and the CSF-related compartments.
5,77
Antigen specificity of patrolling lymphocytes: T cells, after their recognition and reactivation by their cognate antigens presented by APCs residing in the choroid plexus and the meninges, either enter the CSF or remain in these compartments. 8, 87 Therefore, we propose that intracranial adaptive immunity is mediated mainly by lymphocytes that recognize CNS antigens, an outcome of activation by CNS self-antigens presented at the borders. The CSF and the borders as a selective peripheral immunological niche: The composition of leukocytes within the CSF differs from that in the blood. 5, 77 Not only are the predominant blood component, neutrophils, absent from the CSF, the leukocytes that are present in this compartment correspond to unique subpopulations. The T lymphocytes have the phenotype of classical central-memory T lymphocytes, and the monocytes show unique feature of CCR5 þ CCR1 þ populations. Thus, we view the brain's leukocytes as a 'private collection' of a subset of peripheral immune cells, resulting in a selective immunological niche in the healthy CNS. CSF-associated immune deviation: The CNS borders and CSF provide a regulatory milieu that controls the nature of the immune response. 112, 113 We suggest that this results in a population of risk-free autoimmune T cells, as these cells are unlikely to cause overwhelming inflammation. The immunological niche within the CNS territory as the site of 'protective autoimmunity': We suggest that the selective niche within the CNS borders and fluids supplies the brain with the immunological components required for its protection against external and internal threats, as well as for restoration of homeostasis after any deviation-a function termed as 'protective autoimmunity.' 54, 62, 117, 118 It is suggested that CNS surveying lymphocytes contribute to the healthy brain's plasticity (supporting cell renewal, cognition, and mental behavior) by intra-CNS production of regulatory cytokines and growth/survival factors. Through such remote regulation, these cells ensure controlled trophic support effective buffering against cytotoxicity, effective enzymatic detoxification, removal of threats, and metabolic stability. Implications to CNS pathology: According to the proposed principles, pathology emerges when CNS immunosurveillance is inadequate for overcoming deviation from homeostasis.
Implications of the principles: is a failure of CNS immunosurveillance the missing link between mental function and dysfunction?
Increased activity of the brain, whether associated with positive signaling (learning, exercise) or negative activity (stress, anxiety), involves deviations from homeostasis encompassing ionic activity, neurotransmitter release, metabolic changes, and local cellular and molecular events. The ability to restore homeostasis and to re-establish baseline function determines the outcome of such signaling. This restoration is dependent on a myriad of synchronized activities at the electrical, molecular, and cellular levels. Failure to restore homeostasis may lead to malfunctioning of the brain, resulting in abnormal responses to subsequent stimuli. The immune privileged status of the brain, which is commonly explained by the presence of barriers separating this organ from the rest of the body, was interpreted as a means to protect the CNS from immune interference. Actually, the primary function of the BBB in physiology is to maintain ionic balance, 119 whereas the BCSFB actively regulates selective entrance of molecules and immune components to the brain's territory. 5, 77 We propose that CNS immunosurveillance has a pivotal function in the multitude of synchronized activities needed for brain homeostasis, primarily in restoration after activity-induced deviation. This crucial function is provided by the patrolling leukocytes in a remote manner, without needing to penetrate the parenchyma. According to our proposal, a failure in such immunosurveillance, which may take place at any level, at the periphery (hyper-or hypostimulation) or at the CNS (impaired antigen presentation, inappropriate T-cell activation, failure of immune deviation) may result in impaired memory, disturbed attention, and weakened ability to cope with stress. Moreover, inborn, emerging, or age-related peripheral immune malfunctions may underlie emerging of congenital developmental neuropsychological diseases (autism, Tourette syndrome, schizophrenia), aberrant stress responses (depression, post-traumatic stress disorder), or age-related dementia, respectively. This view is also relevant to the transient deviations of the immune response during pregnancy, needed to avoid rejection of the fetus, as is reflected by reduced neurogenesis. 120 In the coming sections, we will describe several examples that emphasize how defects in CNS immunosurveillance may account for mental dysfunction.
Post-traumatic stress disorder and depression-a reflection of insufficient maintenance by patrolling leukocytes? The response to acute stress is based on a fundamental mechanism that evolved in the animal kingdom and equips the individual with the ability to fight, or to escape from a predator. At the level of the brain-immune interactions, this 'fight or flight response' has been linked with the activation of the hypothalamic-pituitary-adrenal axis, and thus serves as a mechanism that explains how the brain signals the rapid dispatch of immune cells to all tissues. 121 The brain, as an immune privileged organ, has not been considered as a target for such trafficking leukocytes. However, recent observations have shown that exposure to predator odor enhances lymphocyte trafficking to the brain, 13 similarly to stress-induced lymphocyte immune surveillance of internal organs, as suggested by Dhabhar and McEwen. 121 When recruitment of leukocytes to the brain's territory is not effective, the ability to restore homeostasis, at least in terms of neuronal BDNF levels, is impaired, 13 leading to stress-related disorders. Mental stress results not only in reduced BDNF production, 122 but also with impaired hippocampal neurogenesis, 123 and thus reinforcing the potential function of leukocytes in restoring homeostasis. 11 As a corollary, encounter with a stressor by animals with suboptimal immunity culminates in the syndrome of post-traumatic stress disorder, 13, 58 whereas boosting levels of T cells protect against negative consequences of stress. 13 Unlike acute stress, chronic mental stress, which often leads to depression, results in suppressed peripheral immunity. 124, 125 Our model would argue that the suppressed peripheral immune system deprives the brain of the assistance needed to restore homeostasis. Interestingly, mental depression is functionally linked to impaired hippocampal neurogenesis and reduction of BDNF expression, 56, 126 both of which are tightly regulated by peripheral leukocytes. 11 In line with this effect, boosting of peripheral immunity to self-brain antigens has been shown to ameliorate depressive behavior with restoration of neurogenesis and BDNF levels.
14 It has been argued that for a psychosocial situation to be stressful, the stressful nature of the event must be consciously noted. The cognitive processes of appraisal are central for determining whether a situation is potentially threatening, entails the potential for harm, is a challenge, or is benign. Here, we propose the immune response within the CSF and brain borders as an additional important factor that is involved not in the appraisal of stress, but in the ability to restore homeostasis after severe deviation. 118 It is tempting to suggest that the immune system also participates in the conscious coding of the stressor, although further studies are needed to test this hypothesis.
Hippocampal-dependent memory and age-related dementia Aging of the brain, which often culminates in dementia, can be viewed as a process of accumulated deviation from homeostasis occurring in parallel in the CNS and in the immune system. Brain aging is manifested by increased microglial activation and intracranial cytotoxicity, 127 whereas aging of the immune system is manifested by the accumulation of suppressor cells. 128 Only recently has a function been attributed to the aged immune system in agerelated brain impairment. 117 Spatial-memory loss in aged mice was shown to correlate with age-related attenuation of the immune response. 55 Expansion of the T-cell repertoire, achieved by homeostatically driven proliferation, restores spatial-memory deficits in these aged animals. Peripheral leukocytes were found to affect aspects of brain's cognitive ability, including controlling of presynaptic proteins. 55 Even more astonishing results are the ones showing that an aged immune system is sufficient to induce dementia. 55 According to our currently proposed model, the aging of the peripheral immune system results in defective CNS immunosurveillance, and thus in reduced ability to restore homeostasis after any mental activity in the elderly. Further studies are needed to identify the initiating defect in this vicious cycle.
Late onset of congenital neuropsychological diseases
Changes in immune activity can also have a delayed effect on behavior. A functional linkage between maternal infection, abnormal cellular immunity, and delayed onset of anomalous behavior was shown. Thus, for example, in an animal model of schizophrenia, prenatal immune infection results in irregular behavior that is manifested only in adulthood. [129] [130] [131] Mounting reports have proposed a connection between systemic inflammation and onset of schizophrenia, viewing the local inflammation seen in this pathology as a reflection of circulating leukocytes attacking the brain. 132, 133 A linkage between autoimmunity and neuropsychological disorders has also been suggested in autism 134, 135 and Tourette's syndrome. 136 According to our proposal, impaired CNS immunosurveillance can by its own account for abnormal behavior. In support to this proposal, schizophrenic patients showed reduced levels of T cells recognizing myelin antigens. 137 Moreover, a similar immune reduction was seen in offspring of mothers prenatally treated with the viral mimetic, Poly I:C. 138 The most striking phenomenon is that immune deficiency alone is sufficient to cause late onset of abnormal behavior, which is reversible by restoration of the immunological pool. 138 Interestingly, abnormal expression of kisspeptin at puberty has been identified as the interface between immune malfunction and late onset of abnormal behavior, measured by prepulse inhibition assay; exogenous administration of a kisspeptin-derived peptide reverses the immune-associated prepulse inhibition impairment. 138 As abnormal prepulse inhibition is a common phenomenon, observed in many neuropsychological disorders, including Tourrette's syndrome, attention disorders, and autism, a linkage between insufficient immune maintenance and behavioral malfunction may be applicable to these diseases, as well.
Overwhelming peripheral inflammation has a negative signature on the mind Although our model focuses on the pivotal supportive function of proper CNS immunosurveillance on the functioning brain, mounting evidence shows that various peripheral immune pathologies lead to mental dysfunction (reviewed in Dantzer et al. 24 and Myint et al. 139 ). In response to a peripheral infection, cancer, or autoimmune diseases (both CNS and non-CNS), the resulting proinflammatory immune signaling to the brain can lead to an exacerbation of disease and the development of depression in vulnerable individuals. Thus, systemic inflammation is an important biological event that might increase the risk of major depressive episodes, much like the more traditional psychosocial factors.
Behavioral abnormalities have been mainly associated with proinflammatory cytokines. Several neuropsychiatric side effects, such as depression, anxiety, psychosis, suicidal ideation, hypomanic mood, and cognitive impairment, were observed in patients treated with interferon-a and interleukin-2. [140] [141] [142] In addition, in animal studies, treatment with proinflammatory cytokine, such as interleukin-1, could induce depressive-like behavior. 143, 144 Proinflammatory cytokines may enhance the activity of the enzyme, indoleamine 2-3, dioxygenase, which in turn increases tryptophan degradation into kynurenine and decreases tryptophan availability in the brain; the reduced levels of tryptophan interfere with the brain's ability to synthesize serotonin, a neurotransmitter, which is necessary for normal mood state. 144 Although proinflammatory cytokines are detrimental in excessive levels, their complete absence is harmful, as well. 145 Investigation of the connection between mental dysfunction under peripheral inflammatory conditions and aberrant immunosurveillance is still in infancy. In CNS autoimmune inflammation, such as in the case of experimental autoimmune encephalomyelitis, which is associated with peripheral immune alterations, a function has been attributed to CNS immunosurveillance in initiation of pathology. 9 Importantly, however, this alteration in the CNS immunosurveillance cannot be taken as a general phenomenon; in contrast to autoimmune diseases of the CNS, the majority of peripheral pathologies are not directly associated with the brain. It is possible that peripheral inflammation affects the brain through a mechanism that escapes or impairs the tight regulation of CNS immunosurveillance.
Conclusion
Our working paradigm attributes a novel function to CNS immunosurveillance, the function of 'protective autoimmunity,' needed for the proper functioning of the mind. We propose the existence of immunological niche within the brain's territory, secured by its restriction to a unique compartment, the brain's borders and fluids, and which contains these protective immune cells that are actively selected at its port of entrance, the choroid plexus. The CNS immune niche consists mainly of self-recognizing T cells that encounter their cognate antigens at the choroid plexus gate. The unique properties of this compartment allow the close proximity between the collected lymphocytes and the affected tissue, the CNS parenchyma, whereas tightly controlling the potential aggressiveness of the immune cells. Accordingly, failure of CNS immunosurveillance, either because of inadequate leukocyte trafficking or because of failure in controlling their activity, may result in brain malfunction and in mind-associated pathologies. Although we have described the crucial function of intracranial immunosurveillance in brain maintenance and protection, one should keep in mind that the peripheral immune system is the source of these leukocytes. Accordingly, failure of CNS immunosurveillance could be an outcome of peripheral insufficiency, peripheral suppression, or premature aging. Yet, extreme peripheral inflammation could lead to mental malfunction, as well. Overall, the pathways we describe suggest a novel understanding of mental function and dysfunction and place the immune system as an integral part of the functioning mind. Thus, this model can suggest novel targets for therapeutic interventions in neuropathological disorders.
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